Save your place

Sign in to WhoBought

Please try again later.

Elevation Oncology, Inc. (ELEV) institutional ownership

Market cap$22M SectorHealthcare
Funds holding · Q4 2025
2
reported ELEV position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q4 2025
Activity unavailable N/A
0 buyers · 2 sellers

Elevation Oncology, Inc. (ELEV) price and institutional activity

Dates

Q4 2025

$0 bought by 0 investors
$0 sold by 2 investors
Barclays PLCOsaic Holdings, Inc.
Bought Sold Totals per quarter; hover a bar for the names.

Elevation Oncology, Inc. (ELEV) institutional activity · 2

Investor Type Est. change Change Δ Own Date
Barclays PLC · Exited
Change −72K Δ Own −100.0% Date Q4 2025
Barclays PLC Exited· Q4 2025 −72K −100.0% Q4 2025
Osaic Holdings, Inc. · Exited
Change −2K Δ Own −100.0% Date Q4 2025
Osaic Holdings, Inc. Exited· Q4 2025 −2K −100.0% Q4 2025
Data through Q4 2025 · filed Mar 19, 2026
2 of 2

Famous investor activity in Elevation Oncology, Inc. (ELEV)

Elevation Oncology, Inc. (ELEV) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Bml Investment Partners, L.P. 5.9M
% of shares outstanding 9.9% Filing date Mar 26, 2025
Bml Investment Partners, L.P. 5.9M 9.9% Mar 26, 2025
Goldman Sachs Group Inc 4.5M
% of shares outstanding 7.6% Filing date Nov 6, 2024
Goldman Sachs Group Inc 4.5M 7.6% Nov 6, 2024
Aisling Capital Iv, LP 2.9M
% of shares outstanding 6.8% Filing date Feb 6, 2024
Aisling Capital Iv, LP 2.9M 6.8% Feb 6, 2024
Tang Capital Management, LLC 3.1M
% of shares outstanding 5.0% Filing date Aug 14, 2025
Tang Capital Management, LLC 3.1M 5.0% Aug 14, 2025
The Vanguard Group 2.6M
% of shares outstanding 4.4% Filing date Jan 30, 2025
The Vanguard Group 2.6M 4.4% Jan 30, 2025
Biotechnology Value Fund L P 2.4M
% of shares outstanding 3.9% Filing date May 15, 2025
Biotechnology Value Fund L P 2.4M 3.9% May 15, 2025
Exoduspoint Capital Management, LP 50K
% of shares outstanding 0.1% Filing date Feb 7, 2024
Exoduspoint Capital Management, LP 50K 0.1% Feb 7, 2024
Frazier Life Sciences Public Fund, L.P. 0
% of shares outstanding 0.0% Filing date Aug 14, 2025
Frazier Life Sciences Public Fund, L.P. 0 0.0% Aug 14, 2025
8 of 10

Elevation Oncology, Inc. (ELEV) ownership FAQ

Who owns ELEV?

2 reporting institutions disclosed ELEV position changes in the Q4 2025 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q4 2025.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.